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SUMMARY
Physiological stem cell function is regulated by secreted factors produced by niche cells. In this 
study, we describe an unbiased approach based on differential single-cell gene expression analysis 
of mesenchymal osteolineage cells close to and further removed from hematopoietic stem/
progenitor cells to identify candidate niche factors. Mesenchymal cells displayed distinct 
molecular profiles based on their relative location. Amongst the genes which were preferentially 
expressed in proximal cells, we functionally examined three secreted or cell surface molecules not 
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previously connected to HSPC biology: the secreted RNase Angiogenin, the cytokine IL18 and the 
adhesion molecule Embigin and discovered that all of these factors are HSPC quiescence 
regulators. Our proximity-based differential single cell approach therefore reveals molecular 
heterogeneity within niche cells and can be used to identify novel extrinsic stem/progenitor cell 
regulators. Similar approaches could also be applied to other stem cell/niche pairs to advance 
understanding of microenvironmental regulation of stem cell function.
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INTRODUCTION
Inter-cellular communications are essential for maintenance of tissue homeostasis and 
response to injury, as exemplified by functional relationship between stem/progenitor cells 
and their microenvironment, or niche. Studies first experimentally validating the niche 
concept leveraged proximity of heterologous cells (Xie and Spradling, 2000). Subsequent 
studies in multiple species and tissues have convincingly demonstrated that the niche serves 
as a critical regulatory unit to ensure preservation and optimal functioning of the stem cell 
pool (Moore and Lemischka, 2006) (Hsu et al., 2014) (Chakkalakal et al., 2012) (Li and 
Clevers, 2010) (Byrd and Kimble, 2009) (Fuentealba et al., 2012).
Hematopoietic stem cell and progenitor cell (HSPC) bone marrow niche has been 
extensively studied (Mendelson and Frenette, 2014) using cell ablation or cell type-specific 
gene deletion experiments (Morrison and Scadden, 2014). Niche participants have been 
defined as including endothelial cells, multiple mesenchymal types: adipocytes, CXCL12+ 
adventitial reticular (CAR) cells, osteolineage cells (OLC), LeptinR+ and nestin+ cells, 
NG2+ arteriolar sheath cells; non-myelinated Schwann cells and hematopoietic cells: 
macrophages and megakaryocytes (Mendelson and Frenette, 2014). The molecular 
regulators defined, however, are limited and most recent studies have focused on CXCL12 
and stem cell factor (Ding and Morrison, 2013; Ding et al., 2012; Greenbaum et al., 2013). 
We sought to seek novel regulators by reverting back to basic principles of niches, that cells 
in close proximity form an interactive physiologic unit. To experimentally exploit that 
principle, we used the microanatomy of HSPC in bone marrow to guide single cell sampling 
and analysis.
We focused on the post-transplant bone marrow niche because of its direct relevance to the 
clinical setting of HSPC recovery following transplantation. We emphasize that the post-
transplant niche critically differs from the homeostatic niche in two major aspects. First, the 
niche functions to support HSPC during regeneration and expansion as opposed to steady 
state when most HSPCs remain dormant. Second, the molecular and cellular composition of 
the post-transplant niche is markedly distinct due to the toxic effect of irradiation 
conditioning on the niche constituents. In particular, perivascular and endothelial cells, 
known to serve as a major source of critical niche factors such as CXCL12 and stem cell 
factor, are destroyed (Zhou et al, 2015) while the osteolineage cells (OLCs), also shown to 
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play a regulatory role in HSPC niche (Calvi et al., 2003; Sugimura et al., 2012; Zhang et al., 
2003), not only survive irradiation but transiently expand (Dominici et al., 2009) thus 
making it feasible to study these cells in the post-transplant setting.
Prior in vivo imaging studies of the post-transplant niche by our group and others 
demonstrated that in irradiated animals, some transplanted HSPC are found in close 
proximity to the endosteal surface and OLCs labeled by col2.3GFP transgene (Lo Celso et 
al., 2009; Xie et al., 2009), as defined by their location within two cell diameters from 
individual OLC. Given that spatial proximity between niche cells and primitive cells governs 
functional organization of stem cell niches from nematodes to mammals (Moore and 
Lemischka, 2006), we reasoned that HSPC-OLC co-localization in the post-transplant bone 
marrow niche may be similarly indicative of a regulatory relationship. If this is the case, it 
implies that OLCs may be heterogeneous: those which are located in close proximity to 
single transplanted HSPC (“proximal OLCs”) are most intimately involved in HSPC control 
while those at the distance (“distal OLCs”) are less likely to be engaged in the niche-related 
function. Therefore, proximal OLC signature, as defined by transcriptional comparison to 
the distal OLC cell subset, could serve as a valuable resource for unbiased identification of 
HSPC regulatory molecules in vivo.
RESULTS
Experimental platform for proximity-based study of HSPC niche
In order to undertake proximity-based analysis of post-transplant bone marrow niche, we 
adapted the same experimental platform as used in the above-mentioned in vivo imaging 
studies (Lo Celso et al., 2009) except for performing the experiments in neonatal col2.3GFP
+ recipients, which offered access to fresh bone tissue without decalcification.
Histological examination of bone sections from newborn animals transplanted with adult 
bone marrow LT-HSCs (lineage-negative (lin-) kit+ Sca1+ [LKS] CD34−Flk2−) fluorescently 
labeled with a lipophilic membrane-bound dye, DiI, demonstrated that at 48 hours, some 
single DiI-labeled cells were found in close proximity to individual OLCs (Figure 1A). For 
the subsequent experiments, proximal OLC was defined as the nearest cell within two cell 
diameters from a single DiI+ cell, while distal OLCs were harvested from the remaining 
OLC pool based on their location at least five HSPC cell diameters away from transplanted 
cells (Figure 1A). We also observed some transplanted DiI+ cells forming clusters, but these 
were usually located away from the OLC-covered endosteal surface and were not part of a 
definition of either proximal or distal OLCs (Figure S1).
Following transplantation, we extracted individual proximal and distal OLCs from fresh 
sections of femoral bones, performed single cell RNA-Seq analysis and validated 
differentially expressed genes as niche-derived HSPC regulators in vivo (Figure 1B). In 
order to retrieve OLCs directly from a section of neonatal trabecular bone, we modified the 
standard patch clamp microscopy platform by introducing additional steps for tissue 
immobilization and in situ enzymatic digestion under direct visual control followed by 
micropipette aspiration (Figure 1C).
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Proximal OLCs have a distinct transcriptional signature
In total, sixteen proximal OLCs and sixteen distal OLCs were retrieved. Following quality 
control assessment of single cell cDNA amplification [see Methods], eight cells from each 
group were selected for single cell RNA-Seq analysis.
To test whether proximal and distal OLCs could be distinguished in an unbiased manner 
based on a genome-wide transcriptional signature, we performed cross-validation tests using 
the “leave-two-out” strategy. Specifically, transcriptional signatures of one proximal and one 
distal OLC were “left out” from the dataset, a machine-learning classifier was trained on the 
remaining cells, and the ability of the classifier to correctly assign the transcriptomes of the 
“left-out” cells to either proximal or distal group was evaluated (Rizzo, 2007). The process 
was repeated for all proximal-distal cell pairs (64 possible combinations in total). Despite a 
small sample size, the majority of “left-out” samples were correctly classified (Figure 2A, 
area under the curve AUC=0.854, p<10−5) indicating that the proximal and distal OLCs 
displayed stable genome-wide transcriptional differences and that the molecular signature 
was reliable even though derived from a modest number of cells.
Single-cell RNA-Seq data exhibits higher levels of technical noise than the bulk 
measurements, as was also the case with our samples. In order to accommodate for 
biological and technical noise and improve the resolution of expression differences at the 
level of individual genes, we developed a probabilistic method, which uses Bayesian 
approach to estimate the likelihood of expression magnitude based on the observed reads for 
a gene in question and the overall error characteristics within the transcriptome of a 
particular single cell sample – Single Cell Differential Expression (SCDE)(Kharchenko et 
al., 2014). By evaluating posterior probability of expression magnitude for a given gene in 
each cell, the method is able to assess the overall likelihood that expression of a gene differs 
between proximal and distal OLCs (Vcam-1 gene shown as a representative example, Figure 
2B, the list of top differentially expressed genes in Table 1). The complete proximal/distal 
OLC database can be accessed via the URL http://pklab.med.harvard.edu/sde/
viewpost.html?dataset=olc
Using the top 200 differentially expressed genes, we found that profiles of proximal OLCs 
are clustered separately from the profiles of distal OLCs (Figure 2C). In particular, gene set 
enrichment analysis showed that proximal OLCs displayed a significant up-regulation of 
genes encoding cell surface proteins (p-value 6.8×10−4, Q-value 0.048; top genes: Vcam1, 
Adam9, Amot) and those involved in immune response (p-value 3.1×10−6, Q-value 0.0090; 
top genes: Map3k14, Cxcl12, Il18), supporting their role in intercellular communications 
(Figure S2). At the level of individual genes, we found that with the exception of c-kit, 
proximal OLCs had significantly higher expression levels of niche-associated molecules 
(most notably Cxcl12 and Vcam-1) as compared to distal OLCs. Further, in accordance with 
prior studies of a regulatory OLC phenotype, proximal OLCs were lineage-committed 
(Runx2+ , Sp7/osterix+, col1a1+) but less mature (Spp1/osteopontinlow, Bglap/
osteocalcinlow, Dmp1low) than distal OLCs (Figure 2D,E). To emphasize, the proximal OLC 
were immature cells of osteolineage, not mature osteoblasts.
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To verify whether proximity-associated OLC heterogeneity revealed by single cell RNA-Seq 
experiments can be also demonstrated within the tissue, we performed fluorescent in situ 
hybridization experiments (RNA Scope), a recently developed method that allows for 
quantitative measures of gene expression (Wang et al., 2012). We focused on one of the 
factors that we also tested for function in vivo, interleukin 18 (IL18). Bone sections from 
newborn col2.3GFP+ animals 48 hours after transplantation with DiI-labeled LT-HSC (the 
identical experimental setting as for cell-harvesting) were examined. We focused on IL 18 
expression in GFP-labeled OLCs, although the IL18 signal was not restricted to these cells, 
as previously reported (Novick et al., 2013). We defined “proximal” (within two cell 
diameters) and distal (greater than five cell diameters) areas as shown and quantified the 
amount of target RNA molecules as a number of dots per GFP+ cell (Figure 2F). We found 
that GFP+ OLCs in the proximal area contain a higher number of IL18 transcripts per cell as 
compared to those located further away (P<2.2×10−4).
Taken together, these data demonstrate that micro-anatomical proximity to a heterologous 
cell acts as a powerful and reliable discriminator between molecularly distinct subset within 
an apparently homogeneous, lineage-restricted cell population and identifies a subset of 
immature OLCs whose signature is consistent with an HSPC regulatory function.
In light of these findings, we set out to test whether the proximal OLC signature could be 
used as a resource for identification of novel non cell-autonomous HSPC regulators in vivo. 
Based on availability of in vivo models for functional testing, we chose three membrane-
bound and secreted factors for further validation: secreted RNase angiogenin (ANG), pro-
inflammatory cytokine interleukin 18 (IL18), and cell adhesion molecule Embigin.
ANG regulates LT-HSC quiescence and self-renewal
ANG is a secreted ribonuclease with established roles in promoting tumor angiogenesis and 
cellular proliferation (Kishimoto et al., 2005). It also acts as a neuronal pro-survival factor in 
amyotrophic lateral sclerosis (ALS) (Greenway et al., 2006).
We found that Ang was expressed at a higher level in proximal OLCs (Figure 3A) and 
undertook a functional evaluation of its role in the bone marrow niche by conditionally 
deleting Ang from distinct niche cell subsets. We crossed Ang “floxed” mice with animals in 
which tamoxifen-inducible Cre-recombinase was driven by the promoters targeting specific 
mesenchymal cells – osteolineage committed progenitors (Osx) (Mizoguchi et al., 2014), 
mesenchymal progenitors (nestin) (Mendez-Ferrer et al., 2010), periarteriolar sheath cells 
(NG2) (Zhu et al., 2011) and mature osteoblasts (Col1a1) (Kim et al., 2004). Ang expression 
in these niche cell subsets has been previously documented (Kunisaki et al., 2013) (Paic et 
al., 2009).
All conditional knock-outs demonstrated no significant changes in peripheral blood or bone 
marrow, apart from mild lymphocytosis (Table 2). However, immunophenotypic analysis of 
primitive hematopoietic cells (Figure S3A) revealed that deletion of Ang from Osx+, Nes+ 
and NG2+ cells resulted in an increase of the number of LT-HSC and more active cycling of 
LT-HSC, short-term HSC (ST-HSC) and multi-potent progenitors (MPP) (Figure 3B,C and 
Figure S3Bi,ii, C, Di,ii). In contrast, Ang deletion in mature osteoblasts by col1a1Cre had no 
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effect on these cell populations, but was associated with an increase in number and more 
active cycling of common lymphoid progenitors (CLP), as was also seen upon Ang deletion 
from Nes+ and NG2+ cells (Figure 3D,E). The number and cell cycle status of the myeloid 
progenitors in any of the above strains were unaffected by the Ang deletion (Figure S3 Biii, 
Diii).
To assess the effect of the above-noted changes on long-term hematopoietic reconstitution, 
we competitively transplanted the bone marrow from Angfl/flOsxCre, Angfl/flNesCre, 
Angfl/flNG2Cre, and Angfl/flCol1a1Cre mice and corresponding controls into congenic WT 
recipients (Figure 3F). We observed significantly reduced long-term multi-lineage 
reconstitution in the recipients of the bone marrow from Angfl/flOsxCre osteoolineage 
progenitors, Angfl/flNesCre, Angfl/flNG2Cre mice while the animals which were 
transplanted with Angfl/flCol1a1Cre mature osteoblast bone marrow displayed only a 
lymphoid reconstitution defect. Taken together, our observations reveal the role of ANG as a 
niche-derived regulator of quiescence and long-term reconstitution LT-HSC, ST-HSC, MPP 
and CLP and highlight differences in the target cell populations depending on a cellular 
source: ANG produced by mesenchymal progenitors, osteolineage committed progenitors 
and peri-arteriolar sheath cells regulates quiescence and repopulating ability of LT-HSC, 
while ANG derived from mature osteoblasts regulates lymphoid progenitors. Our findings 
that the absence of ANG in the microenvironment results in a long-term reconstitution 
defect raised a possibility that exposure to recombinant ANG may activate HSPC self-
renewal program under the conditions of proliferative stress. This hypothesis was tested in a 
follow-up study by us (Goncalves et al, accepted in Cell), which showed that ex-vivo 
treatment of LT-HSC with recombinant ANG prior to transplant or in vivo administration 
post-irradiation significantly enhances the regenerative capacity of HSPC.
IL 18 regulates quiescence of short-term hematopoietic progenitors
IL18 is a component of inflammasome, which is expressed by multiple cell types within and 
outside the bone marrow and stimulates interferon-gamma production by T-cells (Okamura 
et al., 1995), but has no known regulatory effect on HSPCs. We tested it in that setting given 
that our proximity-based analysis revealed IL18 expression in proximal OLCs: none of the 
distal OLCs had detectable IL18 transcripts (Figure 4A).
Notably, we found IL18R1 on the cell surface of short-term progenitors, but not LT-HSC 
(Figure 4B). To determine a functional role for IL18, we evaluated IL18 knock-out 
(IL18KO) mice and while no abnormalities in mature cell number were noted in the bone 
marrow and in peripheral blood at baseline (apart from modest neutrophilia) (Figure S4 A-
C), cell cycle and BrdU incorporation studies revealed increased proliferative rate in short-
term hematopoietic progenitors - ST-HSC and MPP - but not in LT-HSC (Figure 4C and 
Figure S4D). These observations are consistent with IL18 regulating the quiescence of short-
term progenitors.
Because IL18 is a stress-response molecule, we wondered if its effect on HSPC would be 
greater in the setting of recovery from bone marrow injury, such as exposure to the cell 
cycle-specific genotoxin 5-fluorouracil (5-FU). Quantification of progenitor cell subsets 7 
days post-exposure to 5-FU (Broxmeyer et al., 2012) showed a significantly increased 
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frequency of LKS cells, lin− kit+Sca1− myeloid progenitors and CLPs in IL18KO mice, as 
compared to 5-FU-treated WT controls (Figure 4D). In newborn IL18KO animals, loss of 
HSPC quiescence at baseline and exaggerated response to genotoxic injury (busulphan 
exposure in utero) (Bruscia et al., 2006) were also observed (Figure S5E). Taken together, 
these data suggest that IL18 constrains progenitor proliferation.
To further evaluate this function, we treated animals with recombinant IL18 and found that it 
protected LKS cells from 5-FU-induced apoptosis (Figure 4E) but limited the vigor of 
marrow recovery, as evidenced by decreased frequency of lineage-negative cells (Figure 4E). 
The specificity of these findings was confirmed by performing an identical experiment in 
IL18R1KO mice, which were unresponsive to exogenously administered IL18 (Figure S4F). 
Therefore, IL18 can protect progenitors from cell cycle specific genotoxins, but in so doing 
suppresses progenitor response to injury, restraining hematopoietic recovery.
To test if the quiescence-inducing effect of IL18 on short-term progenitors is exerted in a 
non cell-autonomous fashion, we transplanted WT (CD45.1) bone marrow cells into lethally 
irradiated IL18KO or WT recipients (CD45.2). We found that the IL18-deficient 
environment in the recipient animals conferred a significantly faster short-term 
hematopoietic recovery without affecting long-term reconstitution in both primary and 
secondary transplants (Figure S5A). In keeping with this, transplantation of the progenitor-
enriched WT bone marrow fraction (LKS cells) into IL18KO hosts was accompanied by 
approximately 2-fold increase in both myeloid (week 2) and lymphoid (week 4) cells in 
peripheral blood of the recipient animals (Figure 4F). The finding of enhanced early post-
transplant reconstitution in the absence of IL18 signaling was recapitulated in a reciprocal 
experiment, when sorted LKS cells from IL18 receptor knock-out animals were transplanted 
into WT hosts (Figure 4G), indicating that the effect of IL18 on short-term progenitors is 
likely to be direct. In both sets of experiments, enhanced reconstitution was multi-lineage 
but did not persist long-term, consistent with the predominant effect of IL18 on multi-potent 
short-term progenitors (Figure S5B,C). Interestingly, faster proliferation of transplanted LKS 
cells in IL18KO recipients was already evident at 24 hours, as shown by intra-vital imaging 
studies, and was associated with homing further away from the endosteal surface indicating 
that IL18 also regulates progenitor localization in the niche (Figure S5D).
To test if the effect of IL18 on post-transplant progenitor expansion can be exploited 
therapeutically, we transplanted lethally irradiated IL18KO and WT recipients with a 
limiting dose of WT bone marrow and found improved survival in the IL18KO group 
(Figure S5E). Given that IL18R is expressed in human HSPC (Fig. S5F), our results create a 
rationale for further translational studies to test whether that IL18 neutralization might be a 
means of reducing post-transplant cytopenias – a major cause of morbidity and mortality in 
patients.
Embigin regulates HSPC localization and quiescence and defines niche-factor enriched 
OLC subset
Embigin is a cell adhesion molecule of immunoglobulin superfamily (Huang et al., 1990, 
1993). Embigin is thought to enhance integrin-dependent cell substrate adhesion and was 
also shown to promote neuromuscular synapse formation (Lain et al., 2009). Embigin is 
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widely expressed within the hematopoietic system, including primitive hematopoietic cells 
(Pridans et al., 2008), but its function remains obscure.
Our proximity-based analysis showed that proximal OLCs had a significantly higher level of 
Embigin expression compared to distal OLCs (Figure 5A), and we undertook in vivo 
functional studies to evaluate its role as a hematopoietic regulator using anti-Embigin 
monoclonal antibody (Pridans et al., 2008).
We found that injection of WT animals with anti-Embigin is associated with approximately 
2-fold increase in the frequency of LT-HSCs, ST-HSCs, MPP and colony-forming cells as 
compared to those treated with isotype control antibody (Figure 5B,C). Further, there was a 
reduction in the proportion of cells in G0 phase of the cell cycle (Figure 5D) with a 
corresponding increase in S/G2/M phase and increased BrdU incorporation by primitive 
hematopoietic cells (Figure S6A), overall indicating the loss of HSPC quiescence upon anti-
Embigin treatment.
Given that Embigin is a cell adhesion molecule, we tested the effect of anti-Embigin on 
HSPC localization. We found that injection of anti-Embigin resulted in mobilization of 
lineage–negative kit+ progenitors and colony-forming cells (CFC), but not LKS cells, into 
the blood (Figure 5E). On the other hand, intra-vital microscopy studies revealed that either 
in vitro incubation of LKS cells [known to express Embigin] (Forsberg et al., 2010) with 
anti-Embigin or injection of anti-Embigin into lethally irradiated hosts resulted in a 
significantly lower number of transplanted LKS cells reaching calvarial bone marrow as 
compared to an isotype control (Figure 5F,G, left panels, Figure S6B,C), thus consistent with 
Embigin functioning as a homing molecule.
Notably, we observed that WT LKS cells transplanted into anti-Embigin pre-treated 
recipients or those pre-treated with anti-Embigin antibody displayed a higher proliferation 
rate (Figure 5F,G, right panels), measured as a ratio of cell number per calvarial bone 
marrow between 48 hours and 24 hours post-transplant. We verified the imaging data on 
homing and proliferation data by flow cytometric assessment of frequency and cell cycle 
status of transplanted cells (Figure S6 D,E). These results demonstrated that the effect of 
anti-Embigin on HSPC is direct and not primarily driven by depletion of mature leucocytes 
which was previously reported following anti-Embigin administration (Pridans et al., 2008). 
Consistent with the effect of anti-Embigin on HSPC quiescence and homing, bone marrow 
from anti-Embigin treated animals reconstituted poorly when competitively transplanted into 
irradiated recipients as compared to isotype-control treated marrow (Figure S6F). A 
quiescence-inducing effect of Embigin was further confirmed by intra-vital imaging 
experiments using Embigin KO mice which were made available in a limited number 
through collaboration: irradiated WT and Embigin KO animals were transplanted with WT 
LKS cells fluorescently labeled wit DiI, and the number of DiI+ singlets and clusters in the 
calvarial bone marrow were quantified 24 hours post-injection. We observed a significantly 
higher cluster/singlet ratio in Embigin KO recipients, indicative of greater proliferation in 
the absence of niche-derived Embigin (Figure S6G). No homing defect was detectable 
suggesting that the effects of anti-Embigin antibody on HSPC localization may be due to 
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acute Embigin blockade (as opposed to constitutive absence) or downstream signaling upon 
antibody binding which need to be further investigated.
Taken together, our results with are consistent with Embigin function as a regulator of HSPC 
localization and quiescence and provide the rationale for future mechanistic studies to 
examine the role of Embigin in HSPC regeneration.
In addition to identifying the functional role of Embigin in the niche, we asked if Embigin 
can be used as a cell surface marker for prospective isolation of a niche factor-enriched OLC 
subset. We therefore performed flow cytometric analysis of single cell suspensions isolated 
from bones of adult col2.3GFP mice using antibodies against Embigin in combination with 
VCAM1-another cell surface molecule which was preferentially expressed in proximal 
OLCs and easily detectable with commercially available antibody. These experiments 
revealed the presence of a distinct Embigin high VCAM1+population which we termed “VE 
cells” (for VCAM and Embigin)(Figure 6A). Transcriptome comparison of VE and non-VE 
(remaining col2.3GFP+ OLCs) cells demonstrated that VE cells are immature and enriched 
for known HSPC niche factors, thus resembling proximal OLCs (Figure 6B). VE cells had a 
distinct transcriptional profile compared to other niche populations such as nestin-GFPhigh 
and nestin-GFPlow cells, as revealed by PCA analysis (Figure 6C). Since the proximal OLC 
analysis had defined an immunophenotypic method of prospectively isolating similar cells, 
we reasoned that we could now perform flow based isolation and characterization of the VE 
subset under different conditions.
Testing this strategy, we first exposed animals to lethal irradiation to assess the impact of 
conditioning on a specific niche subset. Notably, VE cells increased in frequency and 
displayed up-regulation of two major HSPC retention molecules, CXCL12 and VCAM1, 
while the expression of these molecules in non-VE cells remained unchanged (Figure 6D,E). 
We also then asked whether niche cells ‘see’ and respond to the hematopoietic cells they 
support by examining VE cell gene expression after infusion of either cells or saline post-
irradiation conditioning. Intriguingly, VE cells differentially changed their gene expression 
when LT-HSCs versus saline were injected into lethally irradiated col2.3GFP+ mice. 
Specifically a cell-cell adhesion gene set, as determined by gene set enrichment analysis 
(GSEA), was upregulated (P-value 7.8×10−5, Q-value 0.019, top genes Nrcam, Icam2, 
Esam) whereas non-VE cells did not display consistent changes in this or other GSEA 
pathways tested (Figure 6F and data not shown). Thus, using Embigin as a cell surface 
marker defined a subset of immature OLCs which is enriched in niche factors and displays 
differential responsiveness to local and environmental cues. These data indicate that 
hematopoietic cells regulate their niche: a concept complementing the well-defined notion 
that the niche regulates hematopoietic cells.
DISCUSSION
These studies illustrate several methodological and biological principles. First, we show that 
while single cell analysis has frequently been used to define heterogeneity among admixed 
cells, applied to reveal differential gene expression between cells of specific micro-anatomic 
position can be uniquely powerful in identifying cell subsets and molecules of functional 
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importance. We demonstrate that utilizing the key principle of niche organization – 
mesenchymal-parenchymal proximity – as an upfront biological filter one can define 
otherwise indistinguishable stromal mesenchymal cell subsets. Given that proximity 
between a niche cell and a stem/progenitor cell is a common feature of normal and 
malignant niches, we believe that our approach - possibly in conjunction with other in-situ 
transcriptome analysis platforms such as MER FISH (Chen et al., 2015), FISSEQ (Lee et al., 
2014) or TEVA (Lovatt et al., 2014) – can be more generally applied in other tissue contexts.
Second, we show that combining proximity and single cell analysis can define novel factors 
that regulate neighboring cells. Our approach to regulatory factor identification was unbiased 
since we had no the prior knowledge of the cells which we interrogated (proximal OCLs) 
and the molecules which they produce as being involved in HSPC regulation. We focused on 
signaling molecules that were on the cell surface or secreted and could therefore act in a 
paracrine manner without necessitating direct cell-cell contact, and performed our 
experiments in the setting of transplantation because of our interest in defining molecular 
regulators that may be of relevance to medicine. All three niche factors demonstrated 
potential value in animal models relevant to clinical settings such as sensitivity to 
chemotherapy, recovery from genotoxic insult or hematopoietic regeneration following 
myeloablative transplantation. Perhaps most promisingly from a translational standpoint, our 
follow-up studies (Goncalves et al, accepted in Cell) revealed that ex-vivo exposure of 
mouse or human HSPC to recombinant Angiogenin or systemic administration of ANG 
post-irradiation in mice significantly boosts hematopoietic reconstitution. Thus, our 
discovery platform led to development of novel approaches to enhance hematopoietic 
regeneration in clinic.
Third, we demonstrate that our approach can reveal a subset of proximal-like cells (VE cells) 
that can be subsequently isolated by flow cytometry and molecularly analyzed. Doing so in 
the context of hematopoietic stem cell transplantation, we demonstrate that VE cells display 
a different pattern of gene expression in the presence of transplanted HSPC. These data 
indicate that niche cells are affected by the presence of the stem/progenitor cells they 
support. Therefore, there is bi-directional communication between specific niche stromal 
cells and stem/progenitor cells in the bone marrow. Similar, reciprocally modulating 
functional units may exist in other tissue niches.
It was striking that the three molecules we identified by differential single cell gene 
expression all regulate HSPC quiescence, despite the molecules representing very distinct 
functional classes (a secreted RNAase, a cytokine and an adhesion regulator). This may be 
coincidence, but it does pose the question of whether there are niches in the marrow 
microenvironment that are particularly abundant in quiescence-inducing or activation-
inducing molecules and may therefore serve as function-specific niches.
In summary, we show that reverting to the basic principle of niches that heterologous cells in 
proximity can regulate each other and combining that with differential single cell analysis 
can be a powerful means of identifying new biologically relevant molecular regulators and 
defining concepts like reciprocal interaction. Our proximity-based differential single cell 
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analysis platform can serve as a discovery approach to identify new molecular and cellular 
aspects of niche biology.
METHODS
For the details of animal models, data analysis, flow cytometry, transplantation, 5-FU 
treatment, BrdU incorporation, mobilization experiments and gene expression studies please 
see Extended Experimental Procedures.
Single OLC harvesting and single cell RNA-Seq
Newborn col2.3GFP animals were injected with DiI- labeled LKS CD34−Flk2− adult bone 
marrow cells and sacrificed 48 hours after transplantation. Femurs were dissected, embedded 
in 10% low melting temperature agarose (Lonza) and sectioned at 100μ using a vibratome 
(Leica). Single OLC harvesting was performed using a physiology microscope BX51 
(Olympus) equipped with filters to detect GFP and DiI fluorescence, DIC optics, 
micromanipulators (Eppendorff), real-time imaging camera, peristaltic pump, in-line heater, 
perfusion chamber (Harvard Apparatus) and SAS Air Syringe (Research Instruments). 
Sections were pre-screened for the presence of rare GFP-labeled OLCs located next to single 
DiI-positive transplanted HSCPs, which were found in 1-2 out of 15 sections per animal. 
The section was secured against the bottom of the perfusion chamber with holding pipette 
(Humagen) and was perfused with warm (37°C) cell dissociation solution (Liberase TM, 
Roche) for 8-10 minutes while the target cell was visually monitored. Then, applying 
positive pressure from the micropipette using Air Syringe, hematopoietic cells surrounding 
the target OLC were dislodged to create a 20-30 μ clearing. Finally, the aspiration pipette 
was lowered onto the target OLC, the cell was gently detached from the endosteal surface 
and aspirated. The presence of GFP fluorescence in the aspirated cell inside the aspiration 
pipette was confirmed, and the contents of the pipette was ejected into a PCR tube with the 
lysis buffer for the single cell RNA-Seq (Tang et al., 2009) and frozen immediately at 
−80°C.
Bioinformatics and single cell RNA-Seq data analysis
The differential expression estimates were obtained from single-cell RNA-seq data using the 
approach described in Supplementary Experimental Procedures. The single cell and bulk 
analysis RNA-Seq data has been deposited in GEO under accession number GSE52359. The 
full differential expression analysis can be viewed via the following URL http://
pklab.med.harvard.edu/sde/viewpost.html?dataset=olc
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Proximity-based single cell analysis of the bone marrow niche
(A) Fluorescent microscopy image of femoral bone section from newborn col2.3GFP+ 
animal injected with DiI-labeled adult bone marrow LT-HSCs 48 hours after transplantation. 
Proximal OLC (circled) is defined as the nearest GFP+ cell within two cell diameters (red 
square) from HSPC (arrowhead). Distal cells are GFP+ cells located outside of this area at 
least five cell diameters away from transplanted HSPC (white arrows). Scale bar 10 microne. 
(B) Experimental workflow. (C) Example of micropipette aspiration of proximal OLC. 
Shown are overlaid single color (GFP and DiI) images before and after retrieval of proximal 
OLC (i) The proximal GFP+ OLC (green) was identified based on proximity to the DiI-
labeled HSPC (red). (ii, iii) Following in-situ enzymatic dissociation, HSPC was dislodged 
from its original location and proximal OLC was aspirated into a micropipette. Scale bar 10 
microne.
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Figure 2. Transcriptional profiling of proximal and distal OLCs by single cell RNA-Seq
(A) An unbiased genome-wide classification of proximal and distal OLCs. The receiver-
operator characteristic curve for the Support Vector Machine classification where all 
successive pairs of cells (one proximal and one distal) were classified based on the training 
data provided by other cells (P<0.005). (B) The use of SCDE to estimate the posterior 
distribution of expression levels based on the observations from each cell (colored lines, top 
and bottom panels). Analysis of the Vcam-1 gene is shown as an example. The joint 
posteriors (black lines) describe the overall estimation of likely expression levels within the 
proximal (top) and distal (bottom) OLCs, and are used to estimate the posterior of the 
expression fold difference (middle plot). The shaded area under the fold-difference posterior 
shows 95% confidence region.(C) Classification of individual OLCs based on the top 200 
differentially expressed genes. Each row represents a gene, with the most likely gene 
expression levels indicated by color (blue – high, white – low/absent). (D,E) Expression 
analysis of known niche-derived HSPC regulators and OLC maturation genes. The violin 
plots show the posterior distribution of the expression fold-difference (y-axis, log2 scale) for 
each gene, with the shaded area marking the 95% confidence region (equivalent to the 
middle plot in B). The horizontal solid red lines show the most likely fold-change value. (F) 
Quantification of IL18 expression in neonatal post-transplant bone marrow niche by 
fluorescent in-situ hybridization (RNA Scope). Newborn col2.3GFP+ animals were 
transplanted with DiI-labeled long-term HSCs and sacrificed at 48 hours, as for cell 
harvesting experiments. Frozen sections of fixed undecalcified femoral bones were 
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hybridized with fluorescently-labeled IL18 probe. Maximal intensity projections over 12 
micrones are displayed. Top panel: Lower magnification images illustrating spatial 
definition of “proximal” (within two cell diameters from transplanted HSPC, arrowhead) 
and “distal” (greater than five cell diameters from transplanted HSPC) areas. Bottom panel: 
higher magnification images displaying DAPI stain (blue) and the RNA scope signal (red 
dots). The nuclei of GFP+ cells are circled. IL18 mRNA was quantified by comparing the 
intensity of the RNA scope signal (expressed as the average number of dots per cell) 
between GFP+ cells within proximal and distal areas, and the results are displayed in (E) 
(p<2.2×10−4, 95% confidence intervals are shown, based on the Poisson model of the dot 
occurrences per cell. P-value was estimated using Poisson rate ratio test).
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Figure 3. Conditional deletion of Ang from niche cell subsets leads to the loss of quiescence in LT-
HSCs and CLPs
(A) Comparison of Ang expression in proximal and distal OLCs. (B) LT-HSC number per 
femur and (C) LT-HSC cell cycle status following conditional deletion of Ang from distinct 
niche cell subsets, as per the color-coded legend (n=4-10). Non-shaded graphs: control 
animals, shaded graphs: Ang-deleted animals. (D) CLP number per femur and (E) CLP cell 
cycle status following conditional deletion of Ang from distinct niche cell subsets (n=4-10). 
(F) Long-term reconstitution following competitive (1:1) transplantation of bone marrow 
from control animals (solid lines) and animals with conditional deletion of Ang (broken 
lines) into WT congenic recipients (n=8). *P<0.05, **P<0.01, ***P<0.001. Data are 
presented as mean+/− SEM.
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Figure 4. In vivo analysis of IL18 function in HSPC regulation
(A) Comparison of IL18 expression in proximal and distal OLC. (B) IL18 receptor 
expression in HSPC. Representative histograms are shown (n=3). A comparable cell 
population from IL18R KO mouse was used as a negative control (shaded histogram). (C) 
BrdU incorporation by HSPC in IL18KO mice (n=5). (D) Flow cytometric assessment of 
multi-lineage response to 5-FU in IL18KO mice. The statistical significance was assessed by 
ANOVA. Boxplots illustrating log ratios of cell numbers between 5- FU-treated and vehicle-
treated animals in WT and IL18 groups are shown (n=7). (E) Enumeration of apoptotic LKS 
cells and lin-negative cells in WT animals pre-treated with rIL18 prior to 5-FU exposure 
(n=5). (F) Myeloid and lymphoid reconstitution in IL18KO mice following transplantation 
of (WT) LKS cells (n=7). (G) Myeloid and lymphoid reconstitution following 
transplantation of LKS cells from IL18R1KO or WT animals into WT hosts (n=8 per 
group). *P<0.05, **P<0.01. Data are presented as mean+/− SEM.
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Figure 5. Identification of Embigin as a hematopoietic regulator
(A) Comparison of Embigin expression in proximal and distal OLC. (B) Quantification of 
primitive hematopoietic cells, (C) colony-forming cells and (D) cell cycle status following 
treatment with anti-Embigin or isotype control antibody (n=5). (E) The effect of anti-
Embigin treatment on mobilization of lin−kit+ cells, lin−kit+Sca1+ cells and colony-forming 
cells into peripheral blood (n=4). (F,G) Quantification of homing and proliferation by intra-
vital microscopy following transplantation of WT LKS cells into anti-Embigin-treated host 
or anti-Embigin-treated LKS cells into WT host (n=4). Cell number per calvarial marrow at 
24 hours and calculated proliferation rate based on assessment of cell number by repeat 
imaging at 48 hours comparing are shown. Green – transplanted GFP+ cells, blue – second 
harmonic generation (bone signal). * p<0.05, ** p<0.01. Data are presented as mean+/− 
SEM.
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Figure 6. Isolation and characterization of VCAM+Embiginhigh subset of osteolineage cells (VE 
cells)
(A) Flow cytometric strategy for isolation of VE cells. (B) Expression of known niche 
factors and OLC maturation genes in VE cells from col2.3GFP mice (n=3). (C) Principal 
component analysis of transcriptomes from VE cells, nesitn-GFPhigh and nestin-GFPlow 
cells (n=3). (D) Assessment of VE cell frequency after irradiation (n=4). (E) Changes in 
niche factor expression in VE cells following irradiation. (F) Results of GSEA analysis (cell-
cell adhesion) in VE cells and non-VE cells from LT-HSC-versus saline-injected animals 
(n=3). Data are presented as mean+/− SEM.
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